Company research
Omega Therapeutics, Inc.
CIK 1850838Updated Sep 26, 2026
Filing activity
Latest filing
50 filings on record · 15-12G, EFFECT, POS AM, S-8 POS, 25, SCHEDULE 13G/A.
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 204,366,000Source | 145,998,000Source | 233,333,000Source | 28,083,000Source |
| Property, Plant and Equipment, NetUSD | 5,311,000Source | 4,195,000Source | 3,605,000Source | 3,482,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 68,443,000Source | 70,615,000Source | 186,482,000Source | 22,951,000Source |
| Accounts Receivable | — | — | — | — |
| Assets, CurrentUSD | 89,884,000Source | 137,590,000Source | 229,286,000Source | 24,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,324,000Source | 12,294,000Source | 3,702,000Source | 1,052,000Source |
| Operating Lease, Right-of-Use AssetUSD | 108,736,000Source | 3,668,000Source | — | — |
| Other Assets, NoncurrentUSD | 94,000Source | 204,000Source | 101,000Source | 257,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 146,350,000Source | 40,027,000Source | 32,705,000Source | 17,486,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 55,000Source | 48,000Source | 48,000Source | 5,000Source |
| Additional Paid in CapitalUSD | 392,609,000Source | 343,608,000Source | 335,147,000Source | 1,592,000Source |
| Retained Earnings (Accumulated Deficit)USD | -334,634,000Source | -237,206,000Source | -134,505,000Source | -66,225,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -14,000Source | -479,000Source | -62,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 58,016,000Source | 105,971,000Source | 200,628,000Source | -64,628,000Source |
| Liabilities and EquityUSD | 204,366,000Source | 145,998,000Source | 233,333,000Source | 28,083,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 26,806,000Source | 21,964,000Source | 11,983,000Source | 7,699,000Source |
| Operating Lease, Liability, CurrentUSD | 11,300,000Source | 1,524,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,620,000Source | 3,107,000Source | 2,109,000Source | 1,063,000Source |
| Operating Lease, Liability, NoncurrentUSD | 98,243,000Source | 1,120,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 6,416,000Source | 340,000Source | 853,000Source | 1,055,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 7,914,000Source | 13,841,000Source | 9,475,000Source | 3,277,000Source |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | 0Source | 0Source | 0Source | — |
| Deferred Tax Liabilities, NetUSD | 29,747,000Source | 1,196,000Source | 188,000Source | 242,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 19,869,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 4,000,000Source | 3,333,000Source | — | 3,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 14,885,000Source | 16,603,000Source | 19,869,000Source | 8,732,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 8,793,000Source | 7,753,000Source | 3,184,000Source | 637,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 5,125,000Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | -1,487,000Source | 985,000Source | 1,040,000Source | 138,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -91,510,000Source | -98,515,000Source | -57,609,000Source | -26,133,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 47,515,000Source | -18,060,000Source | -40,399,000Source | -1,808,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,869,000Source | 1,380,000Source | 1,467,000Source | 1,808,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 41,823,000Source | 708,000Source | 261,539,000Source | 48,618,000Source |
| Repayments of Long-term DebtUSD | 1,000,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -2,172,000Source | -115,867,000Source | 163,531,000Source | 20,677,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,723,000Source | 1,263,000Source | 754,000Source | 732,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 8,793,000Source | 7,753,000Source | 3,184,000Source | 637,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 53,000Source | 67,000Source | 93,000Source | 48,000Source |
| DepreciationUSD | 1,568,000Source | 1,564,000Source | 1,387,000Source | 1,146,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 233,000Source | — | 3,000Source | -28,000Source |
| General and Administrative ExpenseUSD | 26,186,000Source | 21,821,000Source | 16,603,000Source | 6,236,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Nonoperating Income (Expense)USD | 2,833,000Source | 65,000Source | -2,248,000Source | -802,000Source |
| Operating ExpensesUSD | 103,355,000Source | 104,839,000Source | 66,176,000Source | 28,645,000Source |
| Operating Lease, ExpenseUSD | — | — | 3,300,000Source | 2,200,000Source |
| Other Nonoperating Income (Expense)USD | 23,000Source | -157,000Source | -28,000Source | -28,000Source |
| Payments of Financing CostsUSD | 15,000Source | — | 15,000Source | — |
| Proceeds from Issuance of Common StockUSD | 488,000Source | — | — | — |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 69,502,000Source | 40,735,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 708,000Source | 274,000Source | 101,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | 144,000Source | — |
| Operating Income (Loss)USD | -100,261,000Source | -102,766,000Source | -66,032,000Source | -28,645,000Source |
| Other Nonoperating Income (Expense)USD | 23,000Source | -157,000Source | -28,000Source | -28,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -97,428,000Source | -102,701,000Source | -68,280,000Source | -29,447,000Source |
| Earnings Per Share, BasicUSD per share | -1.8Source | -2.14Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1.8Source | -2.14Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 54,010,996Source | 47,880,819Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 54,010,996Source | 47,880,819Source | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 26,186,000Source | 21,821,000Source | 16,603,000Source | 6,236,000Source |
| Interest ExpenseUSD | — | — | 910,000Source | 777,000Source |
| Interest Expense, DebtUSD | 1,801,000Source | 1,296,000Source | 998,000Source | 780,000Source |
| Interest Income (Expense), NetUSD | 2,810,000Source | 222,000Source | — | — |
| Nonoperating Income (Expense)USD | 2,833,000Source | 65,000Source | -2,248,000Source | -802,000Source |
| Operating ExpensesUSD | 103,355,000Source | 104,839,000Source | 66,176,000Source | 28,645,000Source |
| Operating Lease, ExpenseUSD | — | — | 3,300,000Source | 2,200,000Source |
| Research and Development ExpenseUSD | 77,169,000Source | 79,996,000Source | 47,865,000Source | 21,063,000Source |